YU18099A - Hormonalni preparat koji sadrži jedinjenje estrogena i progestativno jedinjenje - Google Patents
Hormonalni preparat koji sadrži jedinjenje estrogena i progestativno jedinjenjeInfo
- Publication number
- YU18099A YU18099A YU18099A YU18099A YU18099A YU 18099 A YU18099 A YU 18099A YU 18099 A YU18099 A YU 18099A YU 18099 A YU18099 A YU 18099A YU 18099 A YU18099 A YU 18099A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compound
- concerns
- progestational
- oestroprogestational
- hormonal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
Predmetni pronalazak se odnosi na oblast terapeutske hemije i jos tacnije na oblast hormonskih farmaceutskih tehnika. Jos preciznije predmet pronalaska su novi hormonski farmaceutski preparati okarakterisani time sto su nagradeni od estroprogestativne kombinacije sacinjene od estrogenskog jedinjenja i progestativnog jedinjenja, u kombinaciji ili u smesi sa jednim ili vise farmaceutski prihvatljivih, inertnih, ne-toksicnih ekscipijenata koji su namenjeni za primenu oralnim putem. Predmetni pronalazak se takode odnosi na koriscenje estroprogestativne smese u kojoj estrogenska komponenta i progestativna komponenta se primenjuje u kombinovanom obliku. Sjedinjena kombinacija moze da bude prepisana za primenu na neprekidan ili prekidan nacin, sa stanovista realizacije preparata namenjenog za tretiranje estrogenih deficijencija, za prevenciju osteoporozisa i kardiovaskularnog obolenja kod zena u periodu posle menopauze ili takode za zaustavljanje ovulacije kod zena tokom perioda njihove avarijalne aktivnosti. Predmet pronalaska je takode postupak dobijanje za nove estroprogestativne farmaceutske preparate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612239A FR2754179B1 (fr) | 1996-10-08 | 1996-10-08 | Nouvelle composition hormononale et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
YU18099A true YU18099A (sh) | 2002-03-18 |
Family
ID=9496456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU18099A YU18099A (sh) | 1996-10-08 | 1997-10-08 | Hormonalni preparat koji sadrži jedinjenje estrogena i progestativno jedinjenje |
Country Status (38)
Country | Link |
---|---|
US (4) | US6831073B1 (sh) |
EP (2) | EP0956022B1 (sh) |
JP (1) | JP4883542B2 (sh) |
KR (2) | KR20000048981A (sh) |
CN (3) | CN101229173A (sh) |
AP (1) | AP1171A (sh) |
AR (2) | AR009113A1 (sh) |
AT (2) | ATE353652T1 (sh) |
AU (1) | AU745571B2 (sh) |
BR (1) | BR9712274A (sh) |
CA (1) | CA2268358C (sh) |
CL (1) | CL2011000017A1 (sh) |
CZ (1) | CZ298402B6 (sh) |
DE (3) | DE69737373T2 (sh) |
DK (2) | DK1334725T3 (sh) |
DZ (1) | DZ2327A1 (sh) |
ES (2) | ES2198006T3 (sh) |
FR (2) | FR2754179B1 (sh) |
HK (1) | HK1210708A1 (sh) |
HU (2) | HU227450B1 (sh) |
ID (1) | ID21569A (sh) |
IL (1) | IL129194A (sh) |
LU (1) | LU91932I2 (sh) |
MA (1) | MA24370A1 (sh) |
MY (1) | MY128482A (sh) |
NO (3) | NO324357B1 (sh) |
NZ (1) | NZ334876A (sh) |
OA (1) | OA11033A (sh) |
PL (1) | PL192979B1 (sh) |
PT (2) | PT956022E (sh) |
RU (1) | RU2274450C2 (sh) |
SK (2) | SK285455B6 (sh) |
TN (1) | TNSN97164A1 (sh) |
TR (1) | TR199900764T2 (sh) |
TW (1) | TW491704B (sh) |
WO (1) | WO1998015279A1 (sh) |
YU (1) | YU18099A (sh) |
ZA (1) | ZA979011B (sh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
DE19549264A1 (de) * | 1995-12-23 | 1997-06-26 | Schering Ag | Verfahren und Kit zur Kontrazeption |
WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
WO2001030356A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
FR2823976A1 (fr) * | 2001-04-25 | 2002-10-31 | Theramex | Nouvelle composition hormonale et son utilisation |
UY29185A1 (es) * | 2004-11-02 | 2006-05-31 | Schering Ag | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
PE20081895A1 (es) * | 2007-03-26 | 2009-01-26 | Theramex | Regimen anticonceptivo oral |
US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
US10596103B2 (en) | 2013-12-11 | 2020-03-24 | Merek Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
KR20240005348A (ko) | 2022-07-05 | 2024-01-12 | 신규식 | 소멸특허 관리 및 특허거래 시스템 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271392A (en) * | 1965-09-14 | 1966-09-06 | American Home Prod | 17alpha-[3'-furyl]-estrogens |
US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4921843A (en) | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
JPS61243059A (ja) * | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | 高純度4,4′−ジヒドロキシジフエニルスルホンの製造法 |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
ZA87332B (en) | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
IE61236B1 (en) | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
EP0309263B1 (en) | 1987-09-24 | 1994-03-09 | Jencap Research Limited | Hormone composition and use |
CA1332227C (en) | 1987-09-24 | 1994-10-04 | Robert F. Casper | Oral contraceptive formulation |
US5256421A (en) * | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
HUT52382A (en) | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
IE62665B1 (en) | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
FR2695826B1 (fr) * | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
US6150343A (en) | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
US6613757B1 (en) | 1994-09-22 | 2003-09-02 | Board Of Regents, The University Of Texas System | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
FR2737411B1 (fr) | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
DE19540253C2 (de) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
DE19549264A1 (de) | 1995-12-23 | 1997-06-26 | Schering Ag | Verfahren und Kit zur Kontrazeption |
AU2815897A (en) | 1996-05-08 | 1997-11-26 | American Home Products Corporation | Oral contraceptive |
WO1997041872A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041871A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041869A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1997041870A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
WO1998004267A1 (en) | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
WO1998004246A2 (en) | 1996-07-26 | 1998-02-05 | American Home Prod | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
DK0917466T3 (da) | 1996-07-26 | 2004-12-20 | Wyeth Corp | Oralt antikonceptionsmiddel |
AU3961697A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
AU4043597A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
DE19705229C2 (de) | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
PT1007052E (pt) | 1997-08-27 | 2005-01-31 | Ortho Mcneil Pharm Inc | Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral |
DE19739916C2 (de) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
CN1270521A (zh) | 1997-09-12 | 2000-10-18 | 美国家用产品公司 | 第一阶段包含孕激素/***并且第二阶段包含孕激素的口服避孕制剂 |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
-
1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/fr not_active Expired - Fee Related
-
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/fr unknown
- 1997-10-08 EP EP97944940A patent/EP0956022B1/fr not_active Expired - Lifetime
- 1997-10-08 DK DK03008979T patent/DK1334725T3/da active
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/ru active
- 1997-10-08 PT PT97944940T patent/PT956022E/pt unknown
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/ko not_active IP Right Cessation
- 1997-10-08 PL PL332610A patent/PL192979B1/pl unknown
- 1997-10-08 ID IDW990211A patent/ID21569A/id unknown
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/pt not_active Application Discontinuation
- 1997-10-08 AT AT03008979T patent/ATE353652T1/de active
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 CA CA2268358A patent/CA2268358C/fr not_active Expired - Lifetime
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/sk active Protection Beyond IP Right Term
- 1997-10-08 EP EP03008979A patent/EP1334725B1/fr not_active Expired - Lifetime
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/zh active Pending
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/xx active
- 1997-10-08 AR ARP970104638A patent/AR009113A1/es not_active Application Discontinuation
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/xx unknown
- 1997-10-08 PT PT03008979T patent/PT1334725E/pt unknown
- 1997-10-08 HU HU9904508A patent/HU227450B1/hu active Protection Beyond IP Right Term
- 1997-10-08 NZ NZ334876A patent/NZ334876A/xx not_active IP Right Cessation
- 1997-10-08 AT AT97944940T patent/ATE238057T1/de active
- 1997-10-08 JP JP51726398A patent/JP4883542B2/ja not_active Expired - Lifetime
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 CN CN97180380A patent/CN1239893A/zh active Pending
- 1997-10-08 YU YU18099A patent/YU18099A/sh unknown
- 1997-10-08 IL IL12919497A patent/IL129194A/xx not_active IP Right Cessation
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/zh active Pending
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/cs not_active IP Right Cessation
- 1997-10-08 ES ES97944940T patent/ES2198006T3/es not_active Expired - Lifetime
- 1997-10-08 DE DE69737373T patent/DE69737373T2/de not_active Expired - Lifetime
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/fr active IP Right Grant
- 1997-10-08 DK DK97944940T patent/DK0956022T3/da active
- 1997-10-08 SK SK438-99A patent/SK285056B6/sk not_active IP Right Cessation
- 1997-10-08 ES ES03008979T patent/ES2282539T3/es not_active Expired - Lifetime
- 1997-10-08 MA MA24828A patent/MA24370A1/fr unknown
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/xx unknown
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/ko not_active IP Right Cessation
- 1997-10-08 DE DE69721314T patent/DE69721314T2/de not_active Expired - Lifetime
- 1997-10-15 TW TW086115281A patent/TW491704B/zh not_active IP Right Cessation
-
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/no not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/fr unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
-
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
-
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
-
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/es not_active Application Discontinuation
-
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/es unknown
-
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/fr unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/fr active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/de active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/no not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/hu unknown
-
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/xx unknown
-
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451779B1 (en) | Composition and method for contraception and treatment of tumors of the mammary glands | |
EP0641565B1 (en) | Contraceptive and menstrual cycle controlling drug having oncostatic properties | |
YU18099A (sh) | Hormonalni preparat koji sadrži jedinjenje estrogena i progestativno jedinjenje | |
IL94416A (en) | Pharmaceutical compositions containing dihydrospirorenone | |
US3733407A (en) | Menopause treatment | |
EP1935423A3 (de) | Zusammensetzung zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
RU2005140938A (ru) | Дроспиренон для гормональной заместительной терапии | |
SG153645A1 (en) | Hormone replacement therapy | |
AP1625A (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof. | |
EP0663835A1 (en) | USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS. | |
IL159714A (en) | Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac | |
BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
RU97108279A (ru) | Новые гормональные лекарственные препараты и их применение для коррекции эстрогенной недостаточности | |
JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
FI83593B (fi) | Antikonceptionssammansaettning. | |
AP1707A (en) | Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same. | |
CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
RU2000115313A (ru) | Схемы приема гестаген-анти-гестагена | |
WO2002085375A8 (fr) | Nouvelle composition hormonale et son utilisation | |
Robinson et al. | EORTC Protocol 30853: Orchidectomy versus Zoladex plus flutamide in the management of metastatic carcinoma of the prostate: interim statistical analysis of the side effects of treatment | |
MXPA05003364A (es) | Parche transdermico de 17(-estradiol/levonorgestrel para hormonoterapia restitutiva. | |
EP1178807B1 (en) | Use of org 33245 in combined intermittent hormone therapy and contraception | |
AU2003206424B2 (en) | Sequential estrogen/progesterone antagonist combination for hormone replacement therapy | |
ATE212352T1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate |